| Name | Title | Contact Details |
|---|
Mid Michigan Regional Medical is a Midland, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MolecularHealth delivers on the promise of personalized, precision medicine. By using advanced proprietary information technologies to sift through terabytes of genetic and molecular test findings in a fraction of the time needed for current manual analysis, MolecularHealth provides doctors and patients with faster, more accurate insights into the role genes play in the progression and treatment of an individual’s cancer. MolecularHealth’s team of doctors, scientists, IT and business experts—including founders and executives of LION Bioscience, US Oncology and Novartis—works in partnership with some of the world’s leading healthcare and information technology companies, including the University of Texas MD Anderson Cancer Center, SAP AG, and the U.S. Food and Drug Administration (FDA). The company has locations in The Woodlands, Texas, Boston, Mass. and Heidelberg, Germany.
Sky Lakes Medical Center is a community-owned, internationally accredited acute-care hospital located in Klamath Falls, Oregon, and is the 2021 recipient of the Rural Hospital Leadership Award, which recognizes the hospital`s leadership role and responsiveness to the community`s health needs. Caring for people in a 10,000-square-mile area in south-central Oregon and northwest California, it is licensed for 176 beds. The hospital and its clinics have more than 1,700 employees. Sky Lakes provides a full range of inpatient and outpatient services, a home health agency, a primary care clinic and a variety of specialty physician clinics. The Sky Lakes family also includes the award-winning Sky Lakes Cancer Treatment Center and Cascades East Family Medicine Clinic and residency program.
West Branch Regional Medical Center is a West Branch, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cancer Care Ontario (CCO) – an Ontario government agency – drives quality and continuous improvement in disease prevention and screening, the delivery of care and the patient experience, for cancer, chronic kidney disease, as well as access to care for key health services. Known for its innovation and results-driven approaches, CCO leads multi-year system planning, contracts for services with hospitals and providers, develops and deploys information systems, establishes guidelines and standards, and tracks performance targets to ensure system-wide improvements in cancer, chronic kidney disease – through the Ontario Renal Network – and access to care. Formally launched and funded by the provincial government in 1997, we are governed by an act of legislation called The Cancer Act. As an operational service agency of government, we are accountable to the Minister of Health and Long-Term Care. The details of our relationship with the Ministry are laid out in a formal Memorandum of Understanding (MOU). We follow the management principles of the Government of Ontario. These principles include ethical behavior, accountability, excellence in management, wise use of public funds, high-quality service to the public and equitable access to high-quality service. We are authorized by the Personal Health Information Protection Act to collect and use personal health information to carry out our role in planning and managing the cancer system.